Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Abiomed    ABMD

ABIOMED (ABMD)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/12/2018 11/13/2018 11/14/2018 11/15/2018 11/16/2018 Date
337.86(c) 330.63(c) 312.56(c) 320.78(c) 319.78(c) Last
1 693 034 784 614 1 169 404 931 334 752 891 Volume
-16.61% -2.14% -5.47% +2.63% -0.31% Change
More quotes
Financials (USD)
Sales 2019 773 M
EBIT 2019 224 M
Net income 2019 229 M
Finance 2019 484 M
Yield 2019 -
Sales 2020 991 M
EBIT 2020 306 M
Net income 2020 219 M
Finance 2020 726 M
Yield 2020 -
P/E ratio 2019 64,15
P/E ratio 2020 65,54
EV / Sales2019 18,0x
EV / Sales2020 13,8x
Capitalization 14 403 M
More Financials
Company
ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart.It distributes its products under the Impella brand.The company was founded in 1981 and is headquartered in Danvers, MA. 
More about the company
Surperformance© ratings of Abiomed
Trading Rating : Investor Rating :
More Ratings
Latest news on ABIOMED
11/13ABIOMED : FDA Safety Study of Unloading the Left Ventricle for 30 Minutes Prior ..
AQ
11/11ABIOMED : FDA Safety Study of Unloading the Left Ventricle for 30 Minutes Prior ..
BU
11/09ABIOMED : Change in Directors or Principal Officers (form 8-K/A)
AQ
11/06ABIOMED INC : Change in Directors or Principal Officers (form 8-K)
AQ
11/06ABIOMED INC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
AQ
11/06Two years in, Trump holds stock market bragging rights
RE
11/05ABIOMED : to Present at the Stephens 2018 Investment Conference in New York, NY
AQ
11/02ABIOMED : to Present at the Stephens 2018 Investment Conference in New York, NY
AQ
11/01ABIOMED INC : Results of Operations and Financial Condition, Financial Statement..
AQ
11/01ABIOMED : Fiscal 2Q Earnings Snapshot
AQ
More news
Sector news : Advanced Medical Equipment & Technology - NEC
11/16AGILENT TECHNOLOGIES : Expands Cell Analysis R&D Capabilities in Ireland
DJ
11/12MARKET SNAPSHOT: Stocks Close Sharply Lower As Dow Tumbles 600 Points In Wake..
DJ
11/12ATHENAHEALTH : Veritas Capital, Elliott to buy Athenahealth for $5.7 billion
RE
11/12ATHENAHEALTH : Veritas Capital, Elliott clinch $5.5 billion acquisition of Athen..
RE
11/09GE shares tumble below $9 as JP Morgan analyst cuts price target
RE
More sector news : Advanced Medical Equipment & Technology - NEC
MarketScreener Strategies on ABIOMED 
ABIOMED, INC. - 08/02
The underlying trend is in force again
BUY
ABIOMED, INC. - 2017
Volatility should make a big comeback
BUY
More Strategies
Latest Tweets
08:45aBidaskClub Lowers ABIOMED $ABMD to Hold  
11/16$RETC after we crush 0047 4 cents is next. THATS 1000% HIGHER! 52WKH .29! ?? .. 
11/16$ABMD Abiomed is one of the fastest growing cos. Momo hit hard in 2018. Tes..
11
11/15$RETC u see these MASSIVE BIDS?!? Should tell u a story. Stop sleeping. ??? .. 
11/15$RETC after we crush 0047 4 cents is next. THATS 1000% HIGHER! 52WKH .29! ?? .. 
More tweets
Qtime:109
News from SeekingAlpha
11/12Abiomed down 11% despite positive Impella CP data 
11/02Abiomed Continues To Be An Attractive Investment In 2018 
11/02JPMorgan and Barclays bearish on Puma in premarket healthcare analyst action 
11/01ABIOMED (ABMD) Q2 2019 Results - Earnings Call Transcript 
11/01ABIOMED, Inc. 2018 Q2 - Results - Earnings Call Slides 
Chart ABIOMED
Duration : Period :
Abiomed Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABIOMED
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Average target price 457 $
Spread / Average Target 43%
EPS Revisions
Managers
NameTitle
Michael R. Minogue Chairman, President & Chief Executive Officer
David M. Weber Chief Operating Officer
Todd A. Trapp Chief Financial Officer & Vice President
Thorsten Siess Chief Technology Officer
Seth Bilazarian Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ABIOMED70.63%14 403
THERMO FISHER SCIENTIFIC26.95%97 045
DANAHER CORPORATION11.18%72 333
INTUITIVE SURGICAL42.09%59 217
BOSTON SCIENTIFIC CORPORATION50.10%51 491
ILLUMINA46.43%47 030